{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,12,1]],"date-time":"2025-12-01T15:27:07Z","timestamp":1764602827656},"reference-count":20,"publisher":"Springer Science and Business Media LLC","issue":"10","license":[{"start":{"date-parts":[[2007,8,29]],"date-time":"2007-08-29T00:00:00Z","timestamp":1188345600000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Hautarzt"],"published-print":{"date-parts":[[2007,10]]},"DOI":"10.1007\/s00105-007-1380-3","type":"journal-article","created":{"date-parts":[[2007,8,27]],"date-time":"2007-08-27T11:05:55Z","timestamp":1188212755000},"page":"844-850","source":"Crossref","is-referenced-by-count":7,"title":["Gastrointestinale Beteiligung bei systemischer Sklerose"],"prefix":"10.1007","volume":"58","author":[{"given":"P.","family":"Saar","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"T.","family":"Schmeiser","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"I.H.","family":"Tarner","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"U.","family":"M\u00fcller-Ladner","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2007,8,29]]},"reference":[{"key":"1380_CR1","unstructured":"Saar P, M\u00fcller A, Noethe M et al. (2006) Evaluation des Pilotfragebogens zu Art und Ausma\u00df der gastrointestinalen Beteiligung bei Patienten mit systemischer Sklerose (limitiert\/diffus) im Rahmen des Deutschen Netzwerks f\u00fcr systemische Sklerodermie. Z Rheumatol [Suppl 1]: 61"},{"key":"1380_CR2","doi-asserted-by":"crossref","first-page":"754","DOI":"10.1136\/ard.2006.062901","volume":"66","author":"Walker","year":"2007","unstructured":"Walker UA, Tyndall A, Czirj\u00e1k L et al. (2007) Clinical risk assessment of organ manifestations in systemic sclerosis \u2013 a report from the EULAR Scleroderma Trials and Research (EUSTAR) group data base. Ann Rheum Dis 66: 754\u2013763","journal-title":"Ann Rheum Dis"},{"key":"1380_CR3","doi-asserted-by":"crossref","first-page":"1265","DOI":"10.1002\/art.1780370902","volume":"37","author":"Sj\u00f8gren","year":"1994","unstructured":"Sj\u00f8gren J (1994) Gastrointestinal motility disorders in scleroderma. Arthritis Rheum 37: 1265\u20131282","journal-title":"Arthritis Rheum"},{"key":"1380_CR4","doi-asserted-by":"crossref","first-page":"689","DOI":"10.1016\/j.semarthrit.2004.08.009","volume":"34","author":"Jaovisidha","year":"2005","unstructured":"Jaovisidha K, Csuka ME, Almagro UA, Soergel KH (2005) Severe gastrointestinal involvement in systemic sclerosis: a report of five cases and review of the literature. Semin Arthritis Rheum 34: 689\u2013702","journal-title":"Semin Arthritis Rheum"},{"key":"1380_CR5","doi-asserted-by":"crossref","unstructured":"Manetti M, Neumann E, Milia AF et al. (2007) Severe fibrosis and increased expression of fibrogenic cytokines in the gastric wall of systemic sclerosis patients. Arthritis Rheum (in press)","DOI":"10.1002\/art.22940"},{"key":"1380_CR6","doi-asserted-by":"crossref","first-page":"iii23","DOI":"10.1093\/rheumatology\/kel285","volume":"45","author":"Zuber","year":"2006","unstructured":"Zuber JP, Spertini F (2006) Immunological basis of systemic sclerosis. Rheumatology 45: iii23\u2013iii25","journal-title":"Rheumatology"},{"key":"1380_CR7","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1016\/j.semarthrit.2006.08.002","volume":"36","author":"Stoumazios","year":"2006","unstructured":"Stoumazios SK, Voulgari PV, Potsis K et al. (2006) Esophageal involvement in scleroderma: Gastroesophageal reflux, the common problem. Semin Arthritis Rheum 36: 173\u2013181","journal-title":"Semin Arthritis Rheum"},{"key":"1380_CR8","first-page":"2692","volume":"27","author":"Weber","year":"2000","unstructured":"Weber P, Ganser G, Frosch M et al. (2000) Twenty-four hour intraesophageal pH monitoring in children and adolescents with scleroderma and mixed connective tissue disease. J Rheumatol 27: 2692\u20132695","journal-title":"J Rheumatol"},{"key":"1380_CR9","doi-asserted-by":"crossref","first-page":"2882","DOI":"10.1002\/art.21261","volume":"52","author":"Wipff","year":"2005","unstructured":"Wipff J, Allanore Y, Soussi F et al. (2005) Prevalence of Barrett\u2019s esophagus in systemic sclerosis. Arthritis Rheum 52: 2882\u20132888","journal-title":"Arthritis Rheum"},{"key":"1380_CR10","first-page":"743","volume":"86","author":"Bortolotti","year":"1991","unstructured":"Bortolotti M, Turba E, Tosti A et al. (1991) Gastric emptying and interdigestive antroduodenal motility in patients with esophageal scleroderma. Am J Gastroenterol 86: 743\u2013747","journal-title":"Am J Gastroenterol"},{"key":"1380_CR11","doi-asserted-by":"crossref","first-page":"348","DOI":"10.1080\/03009740410005016","volume":"32","author":"Franck-Larsson","year":"2003","unstructured":"Franck-Larsson K, Hedenstrom H, Dahl R, Ronnblom A (2003) Delayed gastric emptying in patients with diffuse versus limited systemic sclerosis, unrelated to gastrointestinal symptoms and myoelectric gastric activity. Scand J Rheumatol 32: 348\u2013355","journal-title":"Scand J Rheumatol"},{"key":"1380_CR12","doi-asserted-by":"crossref","first-page":"1205","DOI":"10.1097\/00042737-200511000-00009","volume":"17","author":"Sj\u00f6lund","year":"2005","unstructured":"Sj\u00f6lund K, Bartosik I, Lindberg G et al. (2005) Small intestinal manometry in patients with systemic sclerosis. Eur J Gastroenterol Hepatol 17: 1205\u20131212","journal-title":"Eur J Gastroenterol Hepatol"},{"key":"1380_CR13","doi-asserted-by":"crossref","first-page":"226","DOI":"10.1007\/s00296-003-0286-3","volume":"23","author":"Caserta","year":"2003","unstructured":"Caserta L, Magistris L de, Secondulfo M et al. (2003) Assessment of intestinal permeability and orocecal transit time in patients with systemic sclerosis: Analysis of relationships with epidemiologic and clinical parameters. Rheumatol Int 23: 226\u2013230","journal-title":"Rheumatol Int"},{"key":"1380_CR14","doi-asserted-by":"crossref","first-page":"1952","DOI":"10.1016\/S0755-4982(06)74930-2","volume":"35","author":"Marie","year":"2006","unstructured":"Marie I (2006) Gastrointestinal involvement in systemic sclerosis. Presse Med 35: 1952\u20131965","journal-title":"Presse Med"},{"key":"1380_CR15","doi-asserted-by":"crossref","first-page":"446","DOI":"10.1080\/000155502762064593","volume":"82","author":"Massone","year":"2002","unstructured":"Massone C, Milone L, Parodi A et al. (2002) Anorectal involvement is frequent in limited systemic sclerosis. Acta Derm Venereol 82: 446\u2013448","journal-title":"Acta Derm Venereol"},{"key":"1380_CR16","doi-asserted-by":"crossref","first-page":"527","DOI":"10.1097\/00006231-200506000-00008","volume":"26","author":"Linke","year":"2005","unstructured":"Linke R, Meier M, Muenzing W et al. (2005) Prokinetic therapy: What can be measured by gastric scintigraphy? Nucl Med Commun 26: 527\u2013533","journal-title":"Nucl Med Commun"},{"key":"1380_CR17","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1007\/s100670200010","volume":"21","author":"Wang","year":"2002","unstructured":"Wang SJ, Lan JL, Lan JL et al. (2002) Effects of cisapride on colonic transit in patients with progressive systemic sclerosis. Clin Rheumatol 21: 43\u201345","journal-title":"Clin Rheumatol"},{"key":"1380_CR18","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1007\/s100670170038","volume":"20","author":"Wang","year":"2001","unstructured":"Wang SJ, Lan JL, Chen DY et al. (2001) Colonic transit disorders in systemic sclerosis. Clin Rheumatol 20: 251\u2013254","journal-title":"Clin Rheumatol"},{"key":"1380_CR19","first-page":"494","volume":"32","author":"Wollaston","year":"2005","unstructured":"Wollaston DE, Xu X, Tokumaru O et al. (2005) Patients with systemic sclerosis have unique and persistent alterations in gastric myoelectrical activity with acupressure to Neiguan point PC6. J Rheumatol 32: 494\u2013501","journal-title":"J Rheumatol"},{"key":"1380_CR20","doi-asserted-by":"crossref","first-page":"691","DOI":"10.1111\/j.1365-2036.2006.02804.x","volume":"23","author":"Sallam","year":"2006","unstructured":"Sallam H, McNearney TA, Chen JD (2006) Systematic review: Pathophysiology and management of gastrointestinal dysmotility in systemic sclerosis (scleroderma). Aliment Pharmacol Ther 23: 691\u2013712","journal-title":"Aliment Pharmacol Ther"}],"container-title":["Der Hautarzt"],"original-title":[],"language":"de","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00105-007-1380-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00105-007-1380-3\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00105-007-1380-3","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,5,22]],"date-time":"2019-05-22T23:37:17Z","timestamp":1558568237000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00105-007-1380-3"}},"subtitle":["Eine h\u00e4ufig verharmloste Komplikation"],"short-title":[],"issued":{"date-parts":[[2007,8,29]]},"references-count":20,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2007,10]]}},"alternative-id":["1380"],"URL":"https:\/\/doi.org\/10.1007\/s00105-007-1380-3","relation":{},"ISSN":["0017-8470","1432-1173"],"issn-type":[{"value":"0017-8470","type":"print"},{"value":"1432-1173","type":"electronic"}],"subject":[],"published":{"date-parts":[[2007,8,29]]}}}